On June 23, 2025, Revelation Biosciences held its Annual Meeting, where stockholders approved several proposals including a reverse stock split and amendments to the equity incentive plan, although a proposal to change the company's domicile was not passed despite majority support. Notably, 729,206 votes were in favor of the reverse stock split proposal, while 268,216 votes were in favor of changing the domicile from Delaware to Nevada, which needed a greater majority to pass.